首页> 外文期刊>Journal of Medicinal Chemistry >Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2--Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethyl-amine
【24h】

Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor: Synthesis and Subtype Selectivity of N-(4-(2--Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethyl-amine

机译:代谢型谷氨酸2受体的变构增能剂的发现:N-(4-(2-(甲氧基苯氧基)苯基)-N-(2,2,2-三氟乙基磺酰基)吡啶-3-基甲基胺的合成和亚型选择性

获取原文
获取原文并翻译 | 示例
       

摘要

This report describes recently discovered novel allosteric modulators of metabotropic glutamate2 (mGlu2) receptors. These pyridylmethylsulfonamides (e.g., 3) potentiate glutamate, shifting agonist potency by 2-fold. This effect was specific for mGlu2 (vs mGlu1,3-8 receptors). also, 3 failed to potentiate a chimeric mGlu2/1 receptor, demonstrating the mGlu2 transmembrane region's critical involvement. In a fearpotentialted startle model, 3 showed anxoiolytic activity that was prevented by mGlu2/3 antagonist pretreatment. Thus, these pyridylmethylsulfonamides represent the first mGlu2 receptor potentiators discovered.
机译:这份报告描述了最近发现的新型代谢型谷氨酸2(mGlu2)受体的变构调节剂。这些吡啶基甲基磺酰胺(例如3)增强了谷氨酸盐,使激动剂的效力提高了2倍。此作用对mGlu2(相对于mGlu1,3-8受体)具有特异性。同样,3未能增强嵌合的mGlu2 / 1受体,表明mGlu2跨膜区域的关键参与。在一个有潜在恐惧感的惊吓模型中,3显示出抗焦虑活性被mGlu2 / 3拮抗剂预处理所阻止。因此,这些吡啶基甲基磺酰胺代表了第一个发现的mGlu2受体增强剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号